Cargando…
Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
One of the significant challenges for chemotherapy is the appearance of resistance to compounds. Although several signaling pathways have been implicated in the development of Adriamycin (ADM) resistance, mechanisms involved in ADM-resistant osteosarcoma progression remain unknown. The present study...
Autores principales: | Shen, Peng, Cheng, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220921/ https://www.ncbi.nlm.nih.gov/pubmed/32404870 http://dx.doi.org/10.1038/s41419-020-2573-2 |
Ejemplares similares
-
Correction: Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
por: Shen, Peng, et al.
Publicado: (2021) -
Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway
por: Chi, Yuan, et al.
Publicado: (2020) -
Correction to: Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway
por: Chi, Yuan, et al.
Publicado: (2021) -
A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
por: Qu, Le, et al.
Publicado: (2016) -
Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway
por: Zhang, Wei, et al.
Publicado: (2022)